Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Cash Flow Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Cash Flow Quality Index of 10.86x as of June 2023. Operating cash flow of $118.87 Million exceeds net income of $10.94 Million, indicating high earnings quality where cash backs reported profits. Explore 900904 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 900904 cash flow metrics.
Annual Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
Year-by-year earnings quality comparison for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.91x | $207.79 Million | $71.39 Million | ▼ -23.0% |
| 2023 | 3.78x | $215.59 Million | $57.00 Million | ▼ -42.6% |
| 2022 | 6.59x | $319.23 Million | $48.48 Million | ▲ +148.8% |
| 2021 | 2.65x | $184.26 Million | $69.62 Million | ▲ +73.3% |
| 2019 | 1.53x | $128.28 Million | $83.97 Million | ▲ +9.1% |
| 2018 | 1.40x | $148.53 Million | $106.09 Million | ▲ +170.9% |
| 2017 | 0.52x | $66.99 Million | $129.60 Million | ▲ +16397.2% |
| 2016 | 0.00x | $570.41K | $182.06 Million | ▼ -97.7% |
| 2015 | 0.14x | $30.12 Million | $216.73 Million | — |